NON HODGKINS LYMPHOMA
Clinical trials for NON HODGKINS LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NON HODGKINS LYMPHOMA trials appear
Sign up with your email to follow new studies for NON HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktails tested in fight against lymphoma
Disease control OngoingThis study is testing several combinations of a new drug called tafasitamab with other cancer medications in Japanese adults with Non-Hodgkin Lymphoma. It aims to find safe and effective treatment options for people whose cancer has come back or is newly diagnosed. The main goals…
Matched conditions: NON HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New hope for lymphoma patients who have run out of options
Disease control OngoingThis study is testing new combinations of immunotherapy and targeted drugs for adults with B-cell non-Hodgkin's lymphoma that has returned or stopped responding to previous treatments. The main goals are to find safe and effective doses and to see if these combinations can shrink…
Matched conditions: NON HODGKINS LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists gather cancer clues to build future weapons
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood or bone marrow samples from people with blood cancers like leukemia and lymphoma. Researchers will study these samples in the lab to better understand how these cancers work and to find new targets for future treatments. The study does not test a new the…
Matched conditions: NON HODGKINS LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC